+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Barings Corporate

MCINYSE

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$17.99

-0.71-3.80%

Pre-Market: May 20, 7:08 AM EDT

15 minutes delayed

Barings Corporate (MCI) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Barings Corporate (NYSE:MCI) Stock

Barings Corporate Stock (NYSE: MCI)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, May 16, 2024

Barings Corporate Investors Increased Quarter...
Benzinga Newsdesk

Thursday, December 14, 2023

Barings Corporate Investors Announces Increas...
Benzinga Newsdesk

Tuesday, October 10, 2023

Barings Corporate Investors Boosts Quarterly ...
Benzinga Newsdesk

Tuesday, August 22, 2023

Barings Corporate's Ex-Dividend Date Is Friday, Here's What You Need To Know
Benzinga Insights

Thursday, August 17, 2023

Barrings Q2 2023 Net Investment Income $7.7M
Benzinga Newsdesk

Thursday, May 25, 2023

Monday Is Your Last Chance To Buy Barings Corporate Before The Dividend Payout
Benzinga Insights

Thursday, May 18, 2023

Barings Corporate Investors Reports Preliminary Q1 2023 Results; Increases Quarterly Cash Dividend From $0.28 To $0.32/Share
Happy Mohamed

Monday, February 27, 2023

Barings Corporate Investors Reports Preliminary Q4 2022 Results; Net Asset Value Per Share As Of December 31, 2022, Was $16.37, As Compared To $16.59 As Of September 30, 2022
Happy Mohamed

Monday, October 03, 2022

Barings Raises Quarterly Dividend From $0.24 To $0.26
Michael Horton

Tuesday, August 23, 2022

Barings Corporate: Dividend Insights
Benzinga Insights

Thursday, August 18, 2022

Barings Corporate Investors Q2 NII Per Share ...
Bill Haddad

Tuesday, May 24, 2022

Barings Corporate's Ex-Dividend Date Is Friday, Here's What You Need To Know
Benzinga Insights

Wednesday, October 27, 2021

Barings Corporate Sees Q3 2021 Net Investment...
Benzinga Newsdesk

Friday, October 08, 2021

UPDATE: Oppenheimer On Barings BDC Outperform...
Benzinga Newsdesk

Friday, August 13, 2021

Stocks That Hit 52-Week Highs On Friday
Benzinga Insights

Monday, May 17, 2021

Stocks That Hit 52-Week Highs On Monday
Benzinga Insights

Friday, May 14, 2021

Stocks That Hit 52-Week Highs On Friday
Benzinga Insights

Friday, April 23, 2021

Barings Corp Issues Q1 Prelim. Net Increase I...
Benzinga Newsdesk

Thursday, March 19, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin

Wednesday, March 18, 2020

Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin

Monday, March 16, 2020

Stocks That Hit 52-Week Lows On Monday
Lisa Levin

Thursday, March 12, 2020

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin

Wednesday, October 23, 2019

26 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin

Friday, April 17, 2015

Babson Capital Reports Qtr. Net Investment In...
Benzinga

Wednesday, May 07, 2014

Molson Coors Beats Q1 Earnings, Lags Revs - Analyst Blog
Benzinga

Wednesday, November 09, 2011

Go Greek for a Week?
Benzinga

Tuesday, July 19, 2011

Theratechnologies: Results of Independent Study on the Effect of Tesamorelin on Cognitive Function Presented at Conference in France
Benzinga

Thursday, October 07, 2010

Top 5 Stocks With The Highest Dividend Yield (MCI, MPV, WTU, AGNC, ARR)
Benzinga

Tuesday, August 18, 2009

TSX Venture Exchange Closing Summary for August 18, 2009
Benzinga

Monday, August 17, 2009

TSX Venture Exchange Closing Summary for August 17, 2009
Benzinga

Friday, August 14, 2009

TSX Venture Exchange Closing Summary for August 14, 2009
Benzinga
Adeona Pharmaceuticals Announces Second Quarter 2009 Results and Achievements
Benzinga

Thursday, August 13, 2009

TSX Venture Exchange Closing Summary for August 13, 2009
Benzinga
MDN Inc.: Net Income of $1,153,330 or $0.012 Per Share
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved